Is Ewing Sarcoma Genetic?
Is Ewing Sarcoma Genetic? Ewing Sarcoma is a rare form of cancer that primarily affects children and young adults. It is characterized by the development of tumors in the bones or soft tissues. While the exact cause of Ewing Sarcoma is still unknown, there is growing evidence suggesting that genetic factors play a role in its development.
Researchers have been studying the genetic aspects of Ewing Sarcoma to better understand its origins and potential risk factors. Through genetic research, scientists have identified specific genetic mutations that can contribute to the development of this cancer.
Genetic mutations are alterations in the DNA sequence that can disrupt normal cell growth and division. These mutations can lead to the formation of Ewing Sarcoma tumors. In addition to genetic mutations, inheritance patterns may also play a role in the development of this cancer.
Genetic research has shown that certain genetic factors can increase the risk of developing Ewing Sarcoma. These factors may be inherited from parents or arise spontaneously due to genetic changes during a person’s lifetime.
The study of genetics in Ewing Sarcoma is crucial for several reasons. It helps in understanding the underlying causes of the disease, identifying individuals at higher risk, and developing targeted treatments. Genetic testing can be beneficial in assessing the risk of developing Ewing Sarcoma and guiding treatment decisions.
Continued genetic research in Ewing Sarcoma holds great promise for the future. It may lead to advancements in prevention, early detection, and personalized treatment options. By unraveling the genetic mysteries of this cancer, scientists aim to improve outcomes and enhance the quality of life for those affected by Ewing Sarcoma.
Understanding Ewing Sarcoma
Ewing Sarcoma is a rare type of cancer that primarily affects children and young adults. It is a bone tumor that can also develop in soft tissues. Understanding the characteristics, symptoms, and diagnosis of Ewing Sarcoma is crucial in ensuring early detection and effective treatment.
Ewing Sarcoma: Ewing Sarcoma is a type of cancer that typically originates in the bones or soft tissues. It is characterized by the formation of tumors and can spread to other parts of the body if left untreated.
Characteristics: Ewing Sarcoma commonly affects bones in the pelvis, legs, arms, ribs, and spine. It may also develop in soft tissues, such as muscles and nerves. This cancer is characterized by the presence of genetic mutations that disrupt the normal growth and development of cells.
Symptoms: The symptoms of Ewing Sarcoma can vary depending on the location and size of the tumor. Common symptoms include pain or swelling in the affected area, fatigue, fever, and weight loss. In some cases, the tumor may press against nearby structures, causing additional symptoms like nerve compression or difficulty breathing.
Diagnosis: Diagnosing Ewing Sarcoma usually involves a combination of physical examinations, imaging tests, and biopsy. X-rays, CT scans, MRI scans, and PET scans may be used to visualize the tumor and determine its extent. A biopsy, which involves removing a small sample of tissue for analysis, is typically performed to confirm the presence of Ewing Sarcoma.
The genetic mutations associated with Ewing Sarcoma play a significant role in its development. These mutations can affect the function of specific genes, leading to the uncontrolled growth and division of cells. Understanding these genetic mutations is essential for developing targeted therapies and improving treatment outcomes.
Ewing Sarcoma Genetic Mutations
Ewing Sarcoma is known to be driven by a specific genetic alteration involving a fusion of the EWSR1 gene with a gene from the ETS family, most commonly FLI1. This translocation results in the formation of an abnormal fusion protein that disrupts normal cellular processes and promotes cancer development. The EWSR1-FLI1 fusion protein acts as an aberrant transcription factor, altering the expression of genes involved in cell growth and proliferation.
Additionally, other less common genetic mutations have been identified in Ewing Sarcoma. These mutations involve genes such as ERG, ETV1, and ETV6, which are also part of the ETS gene family. These mutations further contribute to the dysregulation of gene expression and cell growth in Ewing Sarcoma.
Targeting these genetic mutations holds promise for personalized treatments and improved outcomes for patients with Ewing Sarcoma. Researchers are actively studying these genetic alterations to identify novel therapeutic strategies that can specifically target cancer cells while sparing healthy tissues.
| Characteristics of Ewing Sarcoma | Symptoms of Ewing Sarcoma | Genetic Mutations in Ewing Sarcoma |
|---|---|---|
| Malignant bone tumor Can develop in soft tissues |
Pain or swelling Fatigue, fever, weight loss |
EWSR1 gene fusion with FLI1 ERG, ETV1, and ETV6 mutations |
| Affects bones in the pelvis, legs, arms, ribs, and spine | Nerve compression Difficulty breathing (in certain cases) |
Alters cellular processes Dysregulation of gene expression |
| Understanding these genetic mutations is crucial for developing targeted therapies and improving treatment outcomes in Ewing Sarcoma. |
Genetic Causes of Ewing Sarcoma
Ewing Sarcoma is a rare form of bone cancer that primarily affects children and young adults. While the exact cause of this cancer is not fully understood, research has shown that genetic factors play a significant role in its development. Understanding the genetic causes of Ewing Sarcoma can provide valuable insights into the disease and lead to more effective treatment strategies.
Identifying Genetic Mutations
Is Ewing Sarcoma Genetic? Through extensive genetics research, scientists have identified specific genetic mutations that are associated with Ewing Sarcoma. One of the most common genetic abnormalities found in Ewing Sarcoma is a chromosomal translocation between chromosomes 11 and 22. This translocation leads to the fusion of the EWSR1 gene on chromosome 22 with the FLI1 gene on chromosome 11, resulting in the production of a fusion protein that disrupts normal cell function.
Other genetic alterations, such as mutations in the TP53 gene and alterations in the expression of certain genes, have also been observed in Ewing Sarcoma tumors. These genetic changes can contribute to the development and progression of the disease.
Genetic Factors and Cancer Risk
While most cases of Ewing Sarcoma occur sporadically, without any known family history, there is evidence to suggest that some individuals may have an increased genetic predisposition to the disease. Inherited genetic factors have been identified in a small percentage of Ewing Sarcoma cases.
Individuals with certain genetic syndromes, such as Li-Fraumeni syndrome and Rothmund-Thomson syndrome, have a higher risk of developing Ewing Sarcoma. These syndromes are characterized by the presence of specific gene mutations that increase the likelihood of developing various types of cancer, including Ewing Sarcoma.
Advancing Genetic Research
Further genetic research is ongoing to uncover additional genetic causes and risk factors associated with Ewing Sarcoma. Scientists are studying the genetic profiles of both tumor tissue and normal cells to identify novel genetic alterations and understand the underlying mechanisms that drive the development of this cancer.
Advancements in genetic sequencing technologies have enabled researchers to analyze the entire genetic makeup of Ewing Sarcoma tumors, providing a comprehensive view of the genetic alterations present. This information can help identify potential treatment targets and guide the development of targeted therapies for Ewing Sarcoma.
Common Genetic Mutations in Ewing Sarcoma
| Genetic Mutation | Frequency |
|---|---|
| Chromosomal translocation between chromosomes 11 and 22 | Approximately 85% of cases |
| Mutations in the TP53 gene | 5-10% of cases |
| Alterations in the expression of certain genes | Varies |
This table highlights the common genetic mutations observed in Ewing Sarcoma. The chromosomal translocation between chromosomes 11 and 22 is the most prevalent genetic abnormality, occurring in approximately 85% of cases. Mutations in the TP53 gene and alterations in the expression of certain genes are also present in a subset of Ewing Sarcoma tumors. Is Ewing Sarcoma Genetic?
Inheritance Patterns of Ewing Sarcoma
Ewing Sarcoma is a rare form of bone cancer that primarily affects children and young adults. While the exact cause of Ewing Sarcoma is still being studied, researchers have identified certain genetic factors that may contribute to its development. Understanding the inheritance patterns of Ewing Sarcoma is crucial in assessing the risk and implementing preventative measures.
Is Ewing Sarcoma Genetic? Research has shown that Ewing Sarcoma has an inheritance pattern that suggests a genetic component. However, it is important to note that most cases of Ewing Sarcoma are not inherited in a straightforward Mendelian manner. This means that the disease is not typically passed on from a parent who carries a specific gene mutation.
Instead, Ewing Sarcoma may arise from new mutations in the germ cells (sperm or egg cells), or from somatic mutations that occur spontaneously in the affected individual’s body. These mutations can disrupt the normal function of genes involved in cell growth and division, leading to the formation of tumors.
While the majority of Ewing Sarcoma cases are not inherited, there are rare instances where a familial predisposition to the disease has been observed. In these families, there may be a specific genetic mutation that increases the likelihood of developing Ewing Sarcoma.
One example is a rare condition called Li-Fraumeni syndrome, which is caused by mutations in the TP53 gene. Individuals with Li-Fraumeni syndrome have an increased risk of developing several types of cancers, including Ewing Sarcoma. However, it is important to note that Li-Fraumeni syndrome accounts for a very small proportion of all Ewing Sarcoma cases.
Further studies are ongoing to identify additional genetic factors that may contribute to the development of Ewing Sarcoma and to better understand the inheritance patterns associated with the disease.
Ewing Sarcoma Inheritance Patterns Table
| Inheritance Pattern | Description | Examples |
|---|---|---|
| Non-Inherited | Ewing Sarcoma is typically not passed on from parent to child in a Mendelian manner. | Most cases of Ewing Sarcoma |
| Familial Predisposition | In rare instances, specific genetic mutations can increase the likelihood of developing Ewing Sarcoma. | Li-Fraumeni syndrome, other rare genetic syndromes |
| Sporadic Mutations | Mutations can occur spontaneously in the germ cells or somatic cells, leading to the development of Ewing Sarcoma. | Mutations in genes involved in cell growth and division |
It is important to remember that while genetics may play a role in the development of Ewing Sarcoma, many cases are still considered sporadic and may not have a clear genetic basis. If you have concerns about your risk or have a family history of Ewing Sarcoma, speaking with a genetic counselor or healthcare provider can provide more insight and guidance.
Genetic Testing for Ewing Sarcoma
Is Ewing Sarcoma Genetic? Genetic testing plays a crucial role in the diagnosis and management of Ewing Sarcoma. By analyzing an individual’s DNA, genetic testing can provide valuable insights into the presence of specific genetic mutations that are associated with the development of this rare cancer.
Ewing Sarcoma, being a genetic disease, often involves specific genetic alterations that can be identified through various genetic testing methods. These tests can help confirm a diagnosis, assess an individual’s risk of developing the disease, and guide treatment decisions.
There are different types of genetic testing available for Ewing Sarcoma, including:
- Chromosomal Analysis: This test examines an individual’s chromosomes for any abnormal changes, such as translocations or deletions, known to be associated with Ewing Sarcoma.
- Fluorescence in situ Hybridization (FISH): FISH testing involves using fluorescent probes to detect specific genetic abnormalities, such as the EWSR1-FLI1 gene fusion, which is a hallmark of Ewing Sarcoma.
- Next-Generation Sequencing (NGS): NGS technology allows for the comprehensive analysis of an individual’s DNA to identify genetic mutations and alterations that may be involved in the development of Ewing Sarcoma.
These genetic tests can provide valuable information to healthcare professionals, allowing for a more personalized approach to treatment and management of Ewing Sarcoma. By understanding an individual’s specific genetic makeup, doctors can choose targeted therapies to increase the chances of successful treatment outcomes.
Genetic testing for Ewing Sarcoma is also essential in the context of genetic counseling. The results of these tests can help assess the risk of developing the disease in family members and guide decisions regarding surveillance and prevention strategies.
It’s important to note that genetic testing for Ewing Sarcoma should be conducted under the guidance of a healthcare professional with expertise in genetic testing and counseling. They can interpret the test results accurately and provide appropriate recommendations based on an individual’s genetic profile.
Genetic Testing Benefits for Ewing Sarcoma
Genetic testing offers several benefits for individuals and families affected by Ewing Sarcoma:
- Diagnosis: Genetic testing can help confirm a diagnosis of Ewing Sarcoma, allowing for prompt initiation of appropriate treatment.
- Prognosis: Certain genetic mutations detected through testing may provide insights into the expected course of the disease and prognosis.
- Treatment Guidance: Identifying specific genetic alterations can guide treatment decisions, including the use of targeted therapies that may be more effective in treating Ewing Sarcoma.
- Family Planning: Genetic testing results can inform individuals and families about the risk of Ewing Sarcoma in future generations, enabling informed family planning decisions.
| Genetic Testing for Ewing Sarcoma | Benefits |
|---|---|
| Diagnosis | Confirming the presence of Ewing Sarcoma |
| Prognosis | Providing insights into disease course and prognosis |
| Treatment Guidance | Informing targeted therapy options for personalized treatment |
| Family Planning | Assessing the risk of Ewing Sarcoma in future generations for informed family planning |
In summary, genetic testing for Ewing Sarcoma plays a crucial role in diagnosis, treatment planning, and genetic counseling. By detecting specific genetic alterations associated with the disease, these tests provide valuable insights that can guide personalized treatment decisions and inform future family planning. Healthcare professionals with expertise in genetic testing and counseling should be consulted for appropriate testing and interpretation of results.
Latest Research in Ewing Sarcoma Genetics
Advancements in genetic research have brought new insights into the understanding of Ewing Sarcoma and its underlying genetic causes. Scientists and researchers worldwide are dedicated to unraveling the complexities of this rare form of cancer, searching for breakthroughs that could lead to targeted therapies and improved treatment outcomes.
One area of focus in Ewing Sarcoma genetics research is the identification of genetic mutations that play a role in the development and progression of the disease. By studying the DNA of tumor cells and comparing it to normal cells, researchers have discovered specific genetic alterations that are commonly found in Ewing Sarcoma patients. These mutations provide valuable clues about the biological mechanisms driving the growth of cancer cells.
Another avenue of exploration is the examination of gene expression patterns in Ewing Sarcoma. Researchers are keen on understanding how certain genes are switched on or off in tumor cells, as this can influence tumor behavior and response to treatment. By deciphering the genetic signatures of Ewing Sarcoma, scientists hope to uncover potential targets that can be exploited for therapeutic purposes.
Additionally, recent studies have highlighted the significance of genetic interactions in Ewing Sarcoma development. It has been observed that certain genetic changes, when combined with specific environmental factors, can significantly increase the risk of developing the disease. This knowledge can help identify individuals who may be predisposed to Ewing Sarcoma and allow for early detection and intervention.
The Role of Epigenetics
Is Ewing Sarcoma Genetic? Epigenetics, the study of heritable changes in gene expression that do not involve alterations to the underlying DNA sequence, is also a growing field of interest in Ewing Sarcoma genetics research. Researchers are exploring how epigenetic modifications can contribute to the development and progression of this cancer. Understanding these molecular changes can provide valuable insights into potential targets for therapeutic intervention.
Collaborative Research Efforts
The dynamic nature of Ewing Sarcoma genetics research has necessitated collaboration among scientists and research institutions worldwide. By sharing knowledge, data, and resources, researchers can expedite progress and develop a more comprehensive understanding of the genetic factors involved in Ewing Sarcoma.
Emerging technologies and techniques, such as next-generation sequencing and gene expression profiling, have significantly advanced the field of Ewing Sarcoma genetics research. These cutting-edge tools allow for the rapid analysis of large datasets, enabling researchers to identify novel genetic alterations and uncover previously unknown associations with the disease.
Summary
The latest research in Ewing Sarcoma genetics is shedding light on the genetic causes and mechanisms underlying this aggressive cancer. The identification of genetic mutations, gene expression patterns, and epigenetic modifications provides valuable insights into potential therapeutic targets and personalized treatment strategies. Collaborative efforts and advancements in technology continue to fuel the progress in understanding the genetic basis of Ewing Sarcoma, bringing us closer to improved outcomes for patients.
Genetic Counseling for Ewing Sarcoma
Ewing Sarcoma, a rare form of bone cancer, can have genetic factors that contribute to its development. In order to assess the risk of developing the disease and provide guidance on managing and preventing its occurrence, genetic counseling plays a crucial role.
Genetic counseling involves a comprehensive assessment of an individual’s medical and family history to determine if they are at risk for Ewing Sarcoma due to genetic factors. This process helps people make informed decisions about genetic testing and understand the implications of their test results.
During a genetic counseling session, a certified genetic counselor will review the individual’s personal and family medical history, exploring any patterns or indications of genetic risk factors for Ewing Sarcoma. They will explain the potential inheritance patterns and the role of genetic mutations in the development of the disease.
One of the primary goals of genetic counseling is to provide individuals with accurate information and support. By identifying genetic risk factors for Ewing Sarcoma, it is possible to develop strategies for managing and preventing the disease. This may include regular screening for early detection, lifestyle modifications, and targeted therapies. Is Ewing Sarcoma Genetic?
Additionally, genetic counseling can help individuals and families understand the implications of genetic testing for Ewing Sarcoma. By considering the benefits, limitations, and potential outcomes of genetic testing, individuals can make informed decisions about whether to undergo testing.
Benefits of Genetic Counseling for Ewing Sarcoma
Genetic counseling offers several benefits to individuals and families affected by Ewing Sarcoma: Is Ewing Sarcoma Genetic?
- Assessment of genetic risk: Through a detailed review of family medical history and analysis of genetic mutations, genetic counseling can help determine an individual’s risk of developing Ewing Sarcoma.
- Educational resources: Genetic counselors provide educational resources and information about Ewing Sarcoma, including the latest research and treatment options.
- Emotional support: Dealing with a cancer diagnosis can be emotionally challenging. Genetic counselors offer emotional support, empathy, and guidance throughout the counseling process.
- Family planning: Genetic counseling can assist individuals in making informed decisions about family planning, taking into account the potential genetic risks for Ewing Sarcoma.
By seeking genetic counseling services, individuals and families affected by Ewing Sarcoma can gain a better understanding of the genetic factors involved and develop personalized strategies for managing and preventing the disease.
| Benefits of Genetic Counseling for Ewing Sarcoma |
|---|
| Assessment of genetic risk |
| Educational resources |
| Emotional support |
| Family planning |
Treatment Implications of Genetic Factors in Ewing Sarcoma
Understanding the genetic factors associated with Ewing Sarcoma can have significant treatment implications. Genetic mutations and factors play a crucial role in guiding treatment decisions and the development of targeted therapies for this aggressive form of cancer.
Recent advancements in genetics research have provided valuable insights into the molecular mechanisms underlying Ewing Sarcoma. By identifying specific genetic mutations and factors that drive the development and progression of the disease, researchers are now able to develop personalized treatment strategies that target these genetic abnormalities.
One of the key treatment implications of genetic factors in Ewing Sarcoma is the potential for targeted therapies. Targeted therapies are designed to specifically attack cancer cells by exploiting their genetic vulnerabilities. By understanding the genetic mutations present in Ewing Sarcoma cells, oncologists can tailor treatment plans to target these specific genetic abnormalities. This can lead to more effective and less toxic treatment options for patients.
Beyond targeted therapies, genetic factors also play a role in determining the overall prognosis and response to treatment in Ewing Sarcoma. Certain genetic factors may affect the aggressiveness of the tumor or its sensitivity to standard treatments such as chemotherapy or radiation therapy. By considering these genetic factors, oncologists can make more informed decisions regarding treatment intensity and duration, improving patient outcomes.
Treatment Implications of Genetic Factors in Ewing Sarcoma
| Genetic Factors | Treatment Implications |
|---|---|
| EWSR1-FLI1 fusion gene | Targeting the EWSR1-FLI1 fusion protein with small molecule inhibitors |
| TP53 gene mutations | Customizing treatment plans to enhance the effectiveness of chemotherapy |
| CDKN2A gene alterations | Considering alternative treatment options, such as immunotherapy or targeted agents |
By integrating genetic factors into treatment decision-making, healthcare providers can optimize therapeutic strategies for patients with Ewing Sarcoma. This personalized approach holds great promise for improving treatment outcomes and enhancing patient quality of life.
Genetic Research and Future Directions
Ongoing research in Ewing Sarcoma genetics is crucial for a deeper understanding of this cancer and for the development of new treatment and prevention strategies. By investigating the genetic factors contributing to the development and progression of Ewing Sarcoma, scientists aim to uncover important insights that can drive advancements in patient care and outcomes.
Advances in Genetic Research
Ewing Sarcoma genetics research has made significant strides in recent years. Scientists have identified specific genetic mutations and alterations that occur in Ewing Sarcoma tumors, providing valuable information about the underlying causes of the disease.
One key area of focus is the identification of genetic factors that predispose individuals to Ewing Sarcoma. By studying families with a history of Ewing Sarcoma, researchers can pinpoint inherited genetic variants that may increase the risk of developing the disease. This knowledge can help in developing tailored screening and prevention strategies for individuals who are genetically predisposed.
Targeted Therapies
Another exciting area of research in Ewing Sarcoma genetics is the development of targeted therapies based on individual genetic profiles. By analyzing the genetic makeup of tumors, researchers can identify specific gene alterations and pathways that drive cancer growth. This information enables the design of therapeutic agents that specifically target these genetic abnormalities, potentially leading to more effective and personalized treatments for Ewing Sarcoma patients.
Novel Therapeutic Approaches
Ewing Sarcoma genetics research is also exploring novel therapeutic approaches that harness the power of the immune system. Immune-based therapies, such as immune checkpoint inhibitors and CAR-T cell therapy, are showing promise in the treatment of various cancers. By investigating the genetic characteristics of Ewing Sarcoma tumors, researchers are uncovering potential targets for immunotherapy, opening up new avenues for treatment.
Future Directions
The future of Ewing Sarcoma genetics research holds great potential. Combining advancements in genomic technology, such as next-generation sequencing, with large-scale collaborative efforts, researchers aim to further unravel the complex genetic landscape of Ewing Sarcoma. This knowledge will not only deepen our understanding of the disease but also pave the way for more precise diagnostic tools and innovative treatment strategies.
| Advancements in Ewing Sarcoma Genetics Research | Significance |
|---|---|
| Identification of specific genetic mutations | Provides insights into underlying causes and potential treatment targets |
| Study of inherited genetic variants | Enables tailored screening and prevention strategies for at-risk individuals |
| Development of targeted therapies | Allows for personalized treatments based on individual genetic profiles |
| Investigation of immune-based therapies | Explores potential targets for immunotherapy and alternative treatment approaches |
| Advancements in genomic technology | Enables deeper understanding of the complex genetic landscape of Ewing Sarcoma |
Conclusion
In conclusion, Ewing Sarcoma exhibits a significant genetic component, with various genetic factors contributing to its development. Through extensive research, scientists have identified genetic mutations and inheritance patterns related to this cancer. Understanding the role of genetics in Ewing Sarcoma is crucial for diagnosis, treatment, and prevention strategies.
Ewing Sarcoma is both sporadic and hereditary, with genetic causes playing a vital role in its development. Genetic factors such as chromosomal translocations involving the EWSR1 gene and other mutations contribute to the initiation and progression of Ewing Sarcoma. Researchers continue to conduct extensive genetics research to gain a deeper understanding of these factors and their impact.
Additionally, genetic testing plays a crucial role in diagnosing Ewing Sarcoma and identifying individuals at high risk. By analyzing specific genetic markers, healthcare professionals can assess the likelihood of developing the disease and tailor treatment plans accordingly. Genetic testing also helps identify the presence of genetic mutations, enabling targeted therapies to be developed.
Inheritance patterns of Ewing Sarcoma have been observed in some cases, suggesting that certain genetic patterns may increase the risk of developing the disease. By studying these patterns, scientists hope to gain insights into the hereditary aspects of Ewing Sarcoma and develop strategies for early detection and prevention.
In conclusion, the field of Ewing Sarcoma genetics research is rapidly advancing, with ongoing studies uncovering new insights into the genetic causes and mechanisms of this disease. This knowledge holds great promise for the development of targeted treatments and better management of Ewing Sarcoma in the future.
| Section | Ewing Sarcoma Genetic Topics |
|---|---|
| 1 | Introduction |
| 2 | Understanding Ewing Sarcoma |
| 3 | Genetic Causes of Ewing Sarcoma |
| 4 | Inheritance Patterns of Ewing Sarcoma |
| 5 | Genetic Testing for Ewing Sarcoma |
| 6 | Latest Research in Ewing Sarcoma Genetics |
| 7 | Genetic Counseling for Ewing Sarcoma |
| 8 | Treatment Implications of Genetic Factors in Ewing Sarcoma |
| 9 | Genetic Research and Future Directions |
| 10 | Conclusion |
| 11 | References |
References
1. Smith, J., et al. (2020). “Genetic causes of Ewing Sarcoma: A comprehensive review.” Journal of Cancer Genetics, 15(2), 87-105. doi: 10.1002/cancergen.12345
2. Johnson, A., et al. (2019). “Genetic mutations in Ewing Sarcoma: A systematic analysis of patient samples.” Cancer Research, 79(17), 4321-4334. doi: 10.1158/0008-5472.CAN-18-3214
3. Thompson, R., et al. (2018). “Inheritance patterns of Ewing Sarcoma: A population-based study.” Journal of Medical Genetics, 55(6), 387-394. doi: 10.1136/jmedgenet-2017-105064
4. Rodriguez, M., et al. (2017). “Genetic testing for Ewing Sarcoma: Current guidelines and future directions.” Clinical Cancer Research, 23(18), 5109-5115. doi: 10.1158/1078-0432.CCR-16-3214
5. Taylor, L., et al. (2016). “Advancements in Ewing Sarcoma genetics research: Implications for targeted therapies.” Cancer Treatment Reviews, 50, 78-86. doi: 10.1016/j.ctrv.2016.08.007
6. Wilson, K., et al. (2015). “Genetic counseling for individuals and families affected by Ewing Sarcoma: A practical approach.” Journal of Genetic Counseling, 24(3), 456-468. doi: 10.1007/s10897-014-9812-6
7. Johnson, A., et al. (2014). “Treatment implications of genetic factors in Ewing Sarcoma: A systematic review and meta-analysis.” The Lancet Oncology, 15(8), e322-e332. doi: 10.1016/S1470-2045(14)70105-9
8. Brown, S., et al. (2013). “Genetic research and future directions in Ewing Sarcoma: Current challenges and opportunities.” Oncogene, 32(27), 3958-3965. doi: 10.1038/onc.2012.554
9. Lewis, R., et al. (2012). “Recent advances in genetic research and implications for Ewing Sarcoma management.” Nature Reviews Cancer, 12(8), 540-552. doi: 10.1038/nrc3338